IDYA
Price
$21.64
Change
+$0.42 (+1.98%)
Updated
Jun 3 closing price
Capitalization
1.9B
69 days until earnings call
IRON
Price
$47.40
Change
-$0.33 (-0.69%)
Updated
Jun 3 closing price
Capitalization
1.65B
65 days until earnings call
Interact to see
Advertisement

IDYA vs IRON

Header iconIDYA vs IRON Comparison
Open Charts IDYA vs IRONBanner chart's image
IDEAYA Biosciences
Price$21.64
Change+$0.42 (+1.98%)
Volume$1.56M
Capitalization1.9B
Disc Medicine
Price$47.40
Change-$0.33 (-0.69%)
Volume$462.79K
Capitalization1.65B
IDYA vs IRON Comparison Chart
Loading...
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDYA vs. IRON commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDYA is a Buy and IRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (IDYA: $21.64 vs. IRON: $47.40)
Brand notoriety: IDYA and IRON are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IDYA: 98% vs. IRON: 104%
Market capitalization -- IDYA: $1.9B vs. IRON: $1.65B
IDYA [@Biotechnology] is valued at $1.9B. IRON’s [@Biotechnology] market capitalization is $1.65B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDYA’s FA Score shows that 0 FA rating(s) are green whileIRON’s FA Score has 0 green FA rating(s).

  • IDYA’s FA Score: 0 green, 5 red.
  • IRON’s FA Score: 0 green, 5 red.
According to our system of comparison, IRON is a better buy in the long-term than IDYA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDYA’s TA Score shows that 6 TA indicator(s) are bullish while IRON’s TA Score has 5 bullish TA indicator(s).

  • IDYA’s TA Score: 6 bullish, 4 bearish.
  • IRON’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both IDYA and IRON are a good buy in the short-term.

Price Growth

IDYA (@Biotechnology) experienced а +11.43% price change this week, while IRON (@Biotechnology) price change was +3.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

IDYA is expected to report earnings on Aug 12, 2025.

IRON is expected to report earnings on Aug 08, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IDYA($1.9B) has a higher market cap than IRON($1.65B). IDYA YTD gains are higher at: -15.798 vs. IRON (-25.237). IRON has higher annual earnings (EBITDA): -114.41M vs. IDYA (-356.46M). IRON (695M) and IDYA (693M) have equal amount of cash in the bank . IDYA has less debt than IRON: IDYA (26M) vs IRON (30.6M). IDYA has higher revenues than IRON: IDYA (7M) vs IRON (0).
IDYAIRONIDYA / IRON
Capitalization1.9B1.65B115%
EBITDA-356.46M-114.41M312%
Gain YTD-15.798-25.23763%
P/E RatioN/AN/A-
Revenue7M0-
Total Cash693M695M100%
Total Debt26M30.6M85%
FUNDAMENTALS RATINGS
IDYA: Fundamental Ratings
IDYA
OUTLOOK RATING
1..100
18
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
62
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IDYAIRON
RSI
ODDS (%)
Bearish Trend 1 day ago
60%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
84%
Bearish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
80%
Advances
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 16 days ago
81%
Declines
ODDS (%)
Bearish Trend 14 days ago
77%
Bearish Trend 8 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
77%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IDYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BMPEX25.480.33
+1.31%
Beck Mack + Oliver Partners
MWOGX47.91N/A
N/A
MFS Global Growth R1
VMCCX51.13N/A
N/A
Virtus KAR Mid-Cap Core C
AULGX97.47N/A
N/A
American Century Ultra® R5
MCECX13.11N/A
N/A
Martin Currie Emerging Markets C

IDYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDYA has been loosely correlated with CGON. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IDYA jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDYA
1D Price
Change %
IDYA100%
+1.98%
CGON - IDYA
60%
Loosely correlated
+0.75%
IMNM - IDYA
59%
Loosely correlated
+2.21%
CRNX - IDYA
56%
Loosely correlated
+0.69%
ETNB - IDYA
55%
Loosely correlated
+0.59%
KRYS - IDYA
55%
Loosely correlated
+4.43%
More

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with KMSTF. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then KMSTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-0.69%
KMSTF - IRON
54%
Loosely correlated
N/A
ATBPF - IRON
53%
Loosely correlated
N/A
CGON - IRON
49%
Loosely correlated
+0.75%
IDYA - IRON
45%
Loosely correlated
+1.98%
ATXS - IRON
45%
Loosely correlated
+3.77%
More